Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC

Abstract excerpt

BACKGROUND: Washington, DC, has 2.5% human immunodeficiency virus (HIV) prevalence, 3.9% among African Americans. Antiretrovirals (ARTs) are the cornerstone for treatment and prevention. Monitoring changes in transmitted drug resistance (TDR) is critical for effective HIV care. METHODS: HIV genotype data for individuals enrolled in research studies in metropolitan Washington, D.C., were used to identify TDR using...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV/AIDS drug development and treatment
• Share to HIV-related health complications and treatments
• Share to HIV Research and Treatment